TY - JOUR
T1 - Canadian stroke best practice consensus statement
T2 - Secondary stroke prevention during pregnancy
AU - Swartz, Richard H.
AU - Ladhani, Noor Niyar N.
AU - Foley, Norine
AU - Nerenberg, Kara
AU - Bal, Simerpreet
AU - Barrett, Jon
AU - Bushnell, Cheryl
AU - Chan, Wee Shian
AU - Chari, Radha
AU - Dowlatshahi, Dariush
AU - Amrani, Meryem El
AU - Gandhi, Shital
AU - Gubitz, Gord
AU - Hill, Michael D.
AU - James, Andra
AU - Jeerakathil, Thomas
AU - Jin, Albert
AU - Kirton, Adam
AU - Lanthier, Sylvain
AU - Lausman, Andrea
AU - Leffert, Lisa Rae
AU - Mandzia, Jennifer
AU - Menon, Bijoy
AU - Pikula, Aleksandra
AU - Poppe, Alexandre
AU - Potts, Jayson
AU - Ray, Joel
AU - Saposnik, Gustavo
AU - Sharma, Mukul
AU - Smith, Eric E.
AU - Bhogal, Sanjit
AU - Smitko, Elisabeth
AU - Lindsay, M. Patrice
N1 - Publisher Copyright:
© 2017, © 2017 World Stroke Organization.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - The Canadian Stroke Best Practice Consensus Statement: Secondary Stroke Prevention during Pregnancy, is the first of a two-part series devoted to stroke in pregnancy. This document focuses on unique aspects of secondary stroke prevention in a woman with a prior history of stroke or transient ischemic attack who is, or is planning to become, pregnant. Although stroke is relatively rare in this cohort, several aspects of pregnancy can increase stroke risk during or immediately after pregnancy. The rationale for the development of this consensus statement is based on the premise that stroke in this group requires a specifically-tailored management approach. No other broad-based, stroke-specific guidelines or consensus statements exist currently. Underpinning the development of this document was the concept that maternal health is vital for fetal wellbeing; therefore, management decisions should be based on the confluence of two clinical considerations: (a) decisions that would be made if the patient was not pregnant and (b) decisions that would be made if the patient had not had a stroke. While empirical research in this area is limited, this consensus document is based on the best available literature and guided by expert consensus. Issues addressed in this document include general management considerations for secondary stroke prevention, the use of antithrombotics, blood pressure management, lipid management, diabetes care, and management for specific ischemic stroke etiologies in pregnancy. The focus is on maternal and fetal health while minimizing risks of a recurrent stroke, through counseling, monitoring, and the safety of select pharmacotherapy. These statements are appropriate for health care professionals across all disciplines.
AB - The Canadian Stroke Best Practice Consensus Statement: Secondary Stroke Prevention during Pregnancy, is the first of a two-part series devoted to stroke in pregnancy. This document focuses on unique aspects of secondary stroke prevention in a woman with a prior history of stroke or transient ischemic attack who is, or is planning to become, pregnant. Although stroke is relatively rare in this cohort, several aspects of pregnancy can increase stroke risk during or immediately after pregnancy. The rationale for the development of this consensus statement is based on the premise that stroke in this group requires a specifically-tailored management approach. No other broad-based, stroke-specific guidelines or consensus statements exist currently. Underpinning the development of this document was the concept that maternal health is vital for fetal wellbeing; therefore, management decisions should be based on the confluence of two clinical considerations: (a) decisions that would be made if the patient was not pregnant and (b) decisions that would be made if the patient had not had a stroke. While empirical research in this area is limited, this consensus document is based on the best available literature and guided by expert consensus. Issues addressed in this document include general management considerations for secondary stroke prevention, the use of antithrombotics, blood pressure management, lipid management, diabetes care, and management for specific ischemic stroke etiologies in pregnancy. The focus is on maternal and fetal health while minimizing risks of a recurrent stroke, through counseling, monitoring, and the safety of select pharmacotherapy. These statements are appropriate for health care professionals across all disciplines.
KW - antithrombotics
KW - hypertension
KW - pregnancy
KW - secondary prevention
KW - statins
KW - Stroke
UR - https://www.scopus.com/pages/publications/85042021055
U2 - 10.1177/1747493017743801
DO - 10.1177/1747493017743801
M3 - Artículo
C2 - 29171360
AN - SCOPUS:85042021055
SN - 1747-4930
VL - 13
SP - 406
EP - 419
JO - International Journal of Stroke
JF - International Journal of Stroke
IS - 4
ER -